0000921895-20-002115.txt : 20200806
0000921895-20-002115.hdr.sgml : 20200806
20200806162347
ACCESSION NUMBER: 0000921895-20-002115
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200805
FILED AS OF DATE: 20200806
DATE AS OF CHANGE: 20200806
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COUCHMAN JONATHAN
CENTRAL INDEX KEY: 0001265094
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36435
FILM NUMBER: 201082067
MAIL ADDRESS:
STREET 1: 630 FIFTH AVENUE
STREET 2: SUITE 2260
CITY: NEW YORK
STATE: NY
ZIP: 10020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Couchman Family Fund
CENTRAL INDEX KEY: 0001737322
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36435
FILM NUMBER: 201082068
BUSINESS ADDRESS:
STREET 1: 630 FIFTH AVENUE, SUITE 2260
CITY: NEW YORK
STATE: NY
ZIP: 10020
BUSINESS PHONE: (212) 729-4962
MAIL ADDRESS:
STREET 1: 630 FIFTH AVENUE, SUITE 2260
CITY: NEW YORK
STATE: NY
ZIP: 10020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Xstelos Corp.
CENTRAL INDEX KEY: 0001571659
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36435
FILM NUMBER: 201082069
BUSINESS ADDRESS:
STREET 1: 630 FIFTH AVENUE
STREET 2: SUITE 2260
CITY: NEW YORK
STATE: NY
ZIP: 10020
BUSINESS PHONE: 212.729.4962
MAIL ADDRESS:
STREET 1: 630 FIFTH AVENUE
STREET 2: SUITE 2260
CITY: NEW YORK
STATE: NY
ZIP: 10020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Myrexis, Inc.
CENTRAL INDEX KEY: 0001459450
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36435
FILM NUMBER: 201082070
BUSINESS ADDRESS:
STREET 1: 600 FIFTH AVENUE, 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10020
BUSINESS PHONE: 801-214-7800
MAIL ADDRESS:
STREET 1: 600 FIFTH AVENUE, 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10020
FORMER NAME:
FORMER CONFORMED NAME: Myriad Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20090324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harper Brian James
CENTRAL INDEX KEY: 0001700373
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36435
FILM NUMBER: 201082071
MAIL ADDRESS:
STREET 1: 6680 GUNPARK DRIVE
STREET 2: SUITE 202B
CITY: BOULDER
STATE: CO
ZIP: 80301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HARPER ASSET MANAGEMENT LLC
CENTRAL INDEX KEY: 0001586910
STATE OF INCORPORATION: GA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36435
FILM NUMBER: 201082072
BUSINESS ADDRESS:
STREET 1: 2945 S CENTER GREEN CT
STREET 2: G215
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 404-451-7432
MAIL ADDRESS:
STREET 1: 2945 S CENTER GREEN CT
STREET 2: G215
CITY: BOULDER
STATE: CO
ZIP: 80301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pearce Michael Cooper
CENTRAL INDEX KEY: 0001413616
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36435
FILM NUMBER: 201082073
MAIL ADDRESS:
STREET 1: 213 RHODODENDRON DRIVE
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000727510
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222372868
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 COMMERCE DRIVE, SUITE 135
CITY: CRANFORD
STATE: NJ
ZIP: 07016
BUSINESS PHONE: 732-980-4500
MAIL ADDRESS:
STREET 1: 20 COMMERCE DRIVE, SUITE 135
CITY: CRANFORD
STATE: NJ
ZIP: 07016
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060324
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20021211
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20021210
4
1
form405735004_08062020.xml
OWNERSHIP DOCUMENT
X0306
4
2020-08-05
0
0000727510
ENZON PHARMACEUTICALS, INC.
ENZN
0001265094
COUCHMAN JONATHAN
600 FIFTH AVENUE
2ND FLOOR
NEW YORK
NY
10020
0
0
1
0
0001737322
Couchman Family Fund
600 FIFTH AVENUE
2ND FLOOR
NEW YORK
NY
10020
0
0
1
0
0001571659
Xstelos Corp.
1105 NORTH MARKET STREET
SUITE 1300
WILMINGTON
DE
19801
0
0
1
0
0001459450
Myrexis, Inc.
600 FIFTH AVENUE
2ND FLOOR
NEW YORK
NY
10020
0
0
1
0
0001700373
Harper Brian James
2248 MARINER DR.
LONGMONT
CO
80503
0
0
0
1
See explanation of responses
0001586910
HARPER ASSET MANAGEMENT LLC
2248 MARINER DR.
LONGMONT
CO
80503
0
0
0
1
See explanation of responses
0001413616
Pearce Michael Cooper
193 AUDUBON TRAIL
CASHIERS
NC
28717
0
0
0
1
See explanation of responses
Common Stock, $0.01 par value
4717666
I
By Jonathan Couchman
Common Stock, $0.01 par value
400000
I
By Couchman Family Fund
Common Stock, $0.01 par value
2020-08-05
4
P
0
506292
0.2000
A
2100524
I
By Xstelos Corp.
Common Stock, $0.01 par value
633264
I
By Myrexis, Inc.
Common Stock, $0.01 par value
1667294
I
By Harper Asset Management LLC
Common Stock, $0.01 par value
0
I
By Michael Pearce
This Form 4 is filed jointly by Jonathan Couchman ("Mr. Couchman"), Couchman Family Fund (the "Foundation"), Xstelos Corp. ("Xstelos") and Myrexis, Inc. ("Myrexis"), Brian Harper, Harper Asset Management, LLC ("HAM"), and Michael Pearce, (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons expressly disclaims beneficial ownership of the Shares reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such Shares for purposes of Section 16 or for any other purpose.
Represents shares owned directly by Mr. Couchman. As the sole trustee of the Foundation, Mr. Couchman may be deemed to beneficially own the Shares owned by the Foundation. As the Chief Executive Officer of Xstelos, Mr. Couchman may be deemed to beneficially own the shares of Common Stock owned by Xstelos. As the Chief Executive Officer of Myrexis, Mr. Couchman may be deemed to beneficially own Shares of Common Stock owned by Myrexis.
Represents Shares owned directly by the Foundation. Mr. Couchman is the sole trustee of the Foundation. By virtue of this relationship, Mr. Couchman may be deemed to beneficially own the Shares owned directly by the Foundation, however he has no pecuniary interest in such Shares.
Represents Shares owned directly by Xstelos. Mr. Couchman is the controlling shareholder and Chief Executive Officer of Xstelos. By virtue of these relationships, Mr. Couchman may be deemed to beneficially own the Shares owned directly by Xstelos. Mr. Couchman expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.
Represents Shares owned directly by Myrexis. Mr. Couchman is Chief Executive Officer of Myrexis. By virtue of this relationship, Mr. Couchman may be deemed to beneficially own the Shares owned directly by Myrexis. Mr. Couchman expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.
Represents shares owned directly by HAM. Mr. Harper is the President of HAM. By virtue of this relationship, Mr. Harper may be deemed to beneficially own the Shares owned directly by HAM. Mr. Harper expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.
Represents shares owned directly by Michael Pearce. Mr. Pearce expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.
/s/ Jonathan Couchman
2020-08-06
Couchman Family Fund; By: /s/ Jonathan Couchman, Trustee
2020-08-06
Xstelos Corp.; By: /s/ Jonathan Couchman, Chief Executive Officer
2020-08-06
Myrexis, Inc.; By: /s/ Jonathan Couchman, Chief Executive Officer
2020-08-06
/s/ Jonathan Couchman, attorney-in-fact for Brian Harper
2020-08-06
Harper Asset Management, LLC; By: /s/ Brian Harper
2020-08-06
/s/ Jonathan Couchman, attorney-in-fact for Michael Pearce
2020-08-06